GAM
BMY icon

Generali Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Generali Asset Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.3M Sell
252,642
-7,485
-3% -$436K 0.32% 69
2025
Q4 		$14M Buy
260,127
+17,840
+7% +$858K 0.29% 76
2025
Q3 		$10.9M Sell
242,287
-47,870
-16% -$2.24M 0.23% 88
2025
Q2 		$13.4M Buy
290,157
+44,727
+18% +$2.2M 0.31% 70
2025
Q1 		$15M Sell
245,430
-38,531
-14% -$2.25M 0.37% 55
2024
Q4 		$16.1M Buy
+283,961
New +$15.9M 0.41% 49

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Generali Asset Management's BMY Position: Q1 2026 in Review

Generali Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 2.9% in Q1 2026, selling an estimated $436K and leaving 252,642 shares worth $15.3M. The position accounts for 0.32% of the portfolio, ranked #69.

Generali Asset Management first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $16.1M in Q4 2024. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Generali Asset Management held 252,642 shares of Bristol-Myers Squibb worth $15.3M as of Q1 2026.
  • Generali Asset Management sold 7,485 Bristol-Myers Squibb shares in Q1 2026, an estimated $436K.
  • Bristol-Myers Squibb made up 0.32% of Generali Asset Management's portfolio in Q1 2026, its #69 holding.
  • Generali Asset Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
  • Generali Asset Management's Bristol-Myers Squibb position peaked at $16.1M in Q4 2024.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Generali Asset Management's 13F filing for Q1 2026, filed 5 May 2026.